Nasopharyngeal Diseases  >>  TheraCIM (nimotuzumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
NCT02012062: Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Completed
3
160
RoW
TPF neoadjuvant chemotherapy, Concurrent chemotherapy with cisplatin during radiotherapy, Concurrent nimotuzumab during radiotherapy, Radical radiotherapy
Fudan University, Fujian Province Tumor Hospital, The First Affiliated Hospital of Xiamen University
Nasopharyngeal Carcinoma
03/16
08/17

Download Options